{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T04:16:37Z","timestamp":1791519397094,"version":"4.3.4"},"reference-count":91,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"16","license":[{"start":{"date-parts":[[2025,7,4]],"date-time":"2025-07-04T00:00:00Z","timestamp":1751587200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,8,20]]},"abstract":"<jats:sec>\n                    <jats:title>Abstract<\/jats:title>\n                    <jats:p>Ischemic stroke (IS) ranks as a leading cause of death and disability globally. The blood-brain barrier (BBB) poses significant challenges for effective drug delivery to brain tissues. Recent decades have seen the development of targeted nanomedicine and biomimetic technologies, sparking substantial interest in biomimetic drug delivery systems for treating IS. These systems are devised by utilizing or replicating natural cells and their derivatives, offering promising new pathways for detection and transport across the BBB. Their multifunctionality and high biocompatibility make them effective treatment options for IS. In addition, the incorporation of engineering techniques has provided these biomimetic drug delivery systems with active targeting capabilities, enhancing the accumulation of therapeutic agents in ischemic tissues and specific cell types. This improvement boosts drug transport and therapeutic efficacy. However, it is crucial to thoroughly understand the advantages and limitations of various engineering strategies employed in constructing biomimetic delivery systems. Selecting appropriate construction methods based on the characteristics of the disease is vital to achieving optimal treatment outcomes. This review summarizes recent advancements in three types of engineered biomimetic drug delivery systems, developed from natural cells and their derivatives, for treating IS. It also discusses their effectiveness in application and potential challenges in future clinical translation.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/cm9.0000000000003685","type":"journal-article","created":{"date-parts":[[2025,7,4]],"date-time":"2025-07-04T06:00:34Z","timestamp":1751608834000},"page":"1945-1960","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":7,"title":["Nano drug delivery system based on natural cells and derivatives for ischemic stroke treatment"],"prefix":"10.1097","volume":"138","author":[{"given":"Wei","family":"Lv","sequence":"first","affiliation":[{"name":"Department of Pharmacy, The Jiangyin Clinical College of Xuzhou Medical University, Wuxi, Jiangsu 214499, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yijiao","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Oncology, The Jiangyin Clinical College of Xuzhou Medical University, Wuxi, Jiangsu 214499, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengnan","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutics, Pharmacy School of Nanjing Medical University, Nanjing, Jiangsu 211166, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kewei","family":"Ren","sequence":"additional","affiliation":[{"name":"Department of Orthopedics, The Jiangyin Clinical College of Xuzhou Medical University, Wuxi, Jiangsu 214499, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hufeng","family":"Fang","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, The Third Affiliated Hospital of Nanjing Medical University, Changzhou Second People\u2019s Hospital, Changzhou, Jiangsu 213100, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, The First Affiliated Hospital with Nanjing Medical University, Nanjing, Jiangsu 210029, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongliang","family":"Xin","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutics, Pharmacy School of Nanjing Medical University, Nanjing, Jiangsu 211166, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,7,4]]},"reference":[{"key":"R1-20250821","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/S1474-4422(16)00114-9","article-title":"Neuroprotection in acute stroke: Targeting excitotoxicity, oxidative and nitrosative stress, and inflammation","volume":"15","author":"Chamorro","year":"2016","journal-title":"Lancet Neurol"},{"key":"R2-20250821","doi-asserted-by":"crossref","first-page":"e93","DOI":"10.1161\/CIR.0000000000001123","article-title":"Heart disease and stroke statistics-2023 update: a report from the american heart association","volume":"147","author":"Tsao","year":"2023","journal-title":"Circulation"},{"key":"R3-20250821","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1016\/j.jacc.2019.12.072","article-title":"Primary and Secondary prevention of\u00a0ischemic stroke and cerebral\u00a0hemorrhage: JACC focus seminar","volume":"75","author":"Diener","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"R4-20250821","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1161\/CIRCULATIONAHA.110.974675","article-title":"Timeliness of tissue-type plasminogen activator therapy in acute ischemic stroke: Patient characteristics, hospital factors, and outcomes associated with door-to-needle times within 60 minutes","volume":"123","author":"Fonarow","year":"2011","journal-title":"Circulation"},{"key":"R5-20250821","doi-asserted-by":"crossref","first-page":"e470","DOI":"10.1016\/j.jstrokecerebrovasdis.2013.05.018","article-title":"Acute kidney injury and edaravone in acute ischemic stroke: The Fukuoka Stroke Registry","volume":"22","author":"Kamouchi","year":"2013","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"R6-20250821","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1136\/svn-2020-000640","article-title":"Effectiveness of intravenous r-tPA versus UK for acute ischaemic stroke: A nationwide prospective Chinese registry study","volume":"6","author":"Wang","year":"2021","journal-title":"Stroke Vasc Neurol"},{"key":"R7-20250821","doi-asserted-by":"crossref","first-page":"2854","DOI":"10.1161\/STROKEAHA.120.030618","article-title":"Cell-based therapy for stroke: Musing with muse cells","volume":"51","author":"Park","year":"2020","journal-title":"Stroke"},{"key":"R8-20250821","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/nrc.2016.108","article-title":"Cancer nanomedicine: progress, challenges and opportunities","volume":"17","author":"Shi","year":"2017","journal-title":"Nat Rev Cancer"},{"key":"R9-20250821","doi-asserted-by":"crossref","first-page":"e1808361","DOI":"10.1002\/adma.201808361","article-title":"Microthrombus-targeting micelles for neurovascular remodeling and enhanced microcirculatory perfusion in acute ischemic stroke","volume":"31","author":"Lu","year":"2019","journal-title":"Adv Mater"},{"key":"R10-20250821","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1021\/acs.nanolett.9b04216","article-title":"Dihydrolipoic acid-gold nanoclusters regulate microglial polarization and have the potential to alter neurogenesis","volume":"20","author":"Xiao","year":"2020","journal-title":"Nano Lett"},{"key":"R11-20250821","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1161\/STROKEAHA.112.675462","article-title":"Enhanced neuroprotection by local intra-arterial infusion of human albumin solution and local hypothermia","volume":"44","author":"Chen","year":"2013","journal-title":"Stroke"},{"key":"R12-20250821","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/j.bbrc.2020.01.032","article-title":"The protective effect of polyethylene glycol-conjugated urokinase nanogels in rat models of ischemic stroke when administrated outside the usual time window","volume":"523","author":"Cui","year":"2020","journal-title":"Biochem Biophys Res Commun"},{"key":"R13-20250821","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1161\/STROKEAHA.117.018290","article-title":"Cell therapy for chronic stroke","volume":"49","author":"Wechsler","year":"2018","journal-title":"Stroke"},{"key":"R14-20250821","doi-asserted-by":"crossref","first-page":"4312","DOI":"10.1021\/acs.nanolett.0c01011","article-title":"Overcoming nanoparticle-mediated complement activation by surface PEG pairing","volume":"20","author":"Pannuzzo","year":"2020","journal-title":"Nano Lett"},{"key":"R15-20250821","doi-asserted-by":"crossref","first-page":"2634","DOI":"10.1007\/s13346-022-01149-y","article-title":"Cell-based carrier for targeted hitchhiking delivery","volume":"12","author":"Liu","year":"2022","journal-title":"Drug Deliv Transl Res"},{"key":"R16-20250821","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1615\/CritRevTherDrugCarrierSyst.2013007419","article-title":"A pharmacokinetic overview of nanotechnology-based drug delivery systems: An ADME-oriented approach","volume":"30","author":"Hamidi","year":"2013","journal-title":"Crit Rev Ther Drug Carrier Syst"},{"key":"R17-20250821","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1080\/10717544.2021.1937384","article-title":"From blood to brain: blood cell-based biomimetic drug delivery systems","volume":"28","author":"Li","year":"2021","journal-title":"Drug Deliv"},{"key":"R18-20250821","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1021\/acsnano.0c07973","article-title":"Neutrophil-like cell-membrane-coated nanozyme therapy for ischemic brain damage and long-term neurological functional recovery","volume":"15","author":"Feng","year":"2021","journal-title":"ACS Nano"},{"key":"R19-20250821","doi-asserted-by":"crossref","first-page":"2314","DOI":"10.1177\/0271678X17700432","article-title":"Neural stem cell transplantation in ischemic stroke: A role for preconditioning and cellular engineering","volume":"37","author":"Bernstock","year":"2017","journal-title":"J Cereb Blood Flow Metab"},{"key":"R20-20250821","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s12975-021-00915-3","article-title":"Extracellular vesicle application as a novel therapeutic strategy for ischemic stroke","volume":"13","author":"Li","year":"2022","journal-title":"Transl Stroke Res"},{"key":"R21-20250821","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.tins.2020.12.002","article-title":"Blood-brain barrier dynamics to maintain brain homeostasis","volume":"44","author":"Segarra","year":"2021","journal-title":"Trends Neurosci"},{"key":"R22-20250821","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.3390\/pharmaceutics12111125","article-title":"Recent advances on ultrasound contrast agents for blood-brain barrier opening with focused ultrasound","volume":"12","author":"Dauba","year":"2020","journal-title":"Pharmaceutics"},{"key":"R23-20250821","doi-asserted-by":"crossref","first-page":"2003937","DOI":"10.1002\/advs.202003937","article-title":"Development of polymeric nanoparticles for blood-brain barrier transfer-strategies and challenges","volume":"8","author":"Zhang","year":"2021","journal-title":"Adv Sci"},{"key":"R24-20250821","doi-asserted-by":"crossref","first-page":"e1801362","DOI":"10.1002\/adma.201801362","article-title":"Overcoming the blood-brain barrier: The role of nanomaterials in treating neurological diseases","volume":"30","author":"Furtado","year":"2018","journal-title":"Adv Mater"},{"key":"R25-20250821","doi-asserted-by":"crossref","first-page":"2306","DOI":"10.1016\/j.apsb.2020.11.023","article-title":"Evolution of blood-brain barrier in brain diseases and related systemic nanoscale brain-targeting drug delivery strategies","volume":"11","author":"Han","year":"2021","journal-title":"Acta Pharm Sin B"},{"key":"R26-20250821","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.neuron.2014.03.003","article-title":"Stepwise recruitment of transcellular and paracellular pathways underlies blood-brain barrier breakdown in stroke","volume":"82","author":"Knowland","year":"2014","journal-title":"Neuron"},{"key":"R27-20250821","doi-asserted-by":"crossref","first-page":"114619","DOI":"10.1016\/j.addr.2022.114619","article-title":"Strategies to overcome\/penetrate the BBB for systemic nanoparticle delivery to the brain\/brain tumor","volume":"191","author":"Liu","year":"2022","journal-title":"Adv Drug Deliv Rev"},{"key":"R28-20250821","doi-asserted-by":"crossref","first-page":"C135","DOI":"10.1152\/ajpcell.00136.2018","article-title":"Neuroinflammatory mechanisms of blood-brain barrier damage in ischemic stroke","volume":"316","author":"Yang","year":"2019","journal-title":"Am J Physiol Cell Physiol"},{"key":"R29-20250821","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1038\/s41573-021-00139-y","article-title":"Strategies for delivering therapeutics across the blood-brain barrier","volume":"20","author":"Terstappen","year":"2021","journal-title":"Nat Rev Drug Discov"},{"key":"R30-20250821","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.jconrel.2017.12.015","article-title":"Crossing the blood-brain barrier with nanoparticles","volume":"270","author":"Zhou","year":"2018","journal-title":"J Control Release"},{"key":"R31-20250821","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/j.addr.2011.10.007","article-title":"Nanotechnological advances for the delivery of CNS therapeutics","volume":"64","author":"Wong","year":"2012","journal-title":"Adv Drug Deliv Rev"},{"key":"R32-20250821","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jconrel.2017.02.019","article-title":"Engineered polymeric nanoparticles to guide the cellular internalization and trafficking of small interfering ribonucleic acids","volume":"259","author":"Arnold","year":"2017","journal-title":"J Control Release"},{"key":"R33-20250821","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.addr.2012.09.037","article-title":"Liposomal drug delivery systems: From concept to clinical applications","volume":"65","author":"Allen","year":"2013","journal-title":"Adv Drug Deliv Rev"},{"key":"R34-20250821","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.colsurfb.2016.08.002","article-title":"PEGylated polyamidoamine dendrimer conjugated with tumor homing peptide as a potential targeted delivery system for glioma","volume":"147","author":"Jiang","year":"2016","journal-title":"Colloids Surf B Biointerfaces"},{"key":"R35-20250821","doi-asserted-by":"crossref","first-page":"5864","DOI":"10.1021\/acsami.6b15831","article-title":"Peptide-22 and cyclic RGD functionalized liposomes for glioma targeting drug delivery overcoming BBB and BBTB","volume":"9","author":"Chen","year":"2017","journal-title":"ACS Appl Mater Interfaces"},{"key":"R36-20250821","doi-asserted-by":"crossref","first-page":"628663","DOI":"10.3389\/fnins.2021.628663","article-title":"Induced pluripotent stem cells for ischemic stroke treatment","volume":"15","author":"Duan","year":"2021","journal-title":"Front Neurosci"},{"key":"R37-20250821","doi-asserted-by":"crossref","first-page":"637210","DOI":"10.3389\/fncel.2021.637210","article-title":"Insight Into the mechanisms and the challenges on stem cell-based therapies for cerebral ischemic stroke","volume":"15","author":"Liu","year":"2021","journal-title":"Front Cell Neurosci"},{"key":"R38-20250821","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1161\/01.CIR.0000084828.50310.6A","article-title":"Systemic delivery of bone marrow-derived mesenchymal stem cells to the infarcted myocardium: feasibility, cell migration, and body distribution","volume":"108","author":"Barbash","year":"2003","journal-title":"Circulation"},{"key":"R39-20250821","doi-asserted-by":"crossref","first-page":"5929","DOI":"10.7150\/thno.28029","article-title":"Targeted homing of CCR2-overexpressing mesenchymal stromal cells to ischemic brain enhances post-stroke recovery partially through PRDX4-mediated blood-brain barrier preservation","volume":"8","author":"Huang","year":"2018","journal-title":"Theranostics"},{"key":"R40-20250821","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.ijpharm.2017.08.073","article-title":"Peptide modified mesenchymal stem cells as targeting delivery system transfected with miR-133b for the treatment of cerebral ischemia","volume":"531","author":"Huang","year":"2017","journal-title":"Int J Pharm"},{"key":"R41-20250821","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.jns.2012.01.001","article-title":"Overexpression of CXCR4 in mesenchymal stem cells promotes migration, neuroprotection and angiogenesis in a rat model of stroke","volume":"316","author":"Yu","year":"2012","journal-title":"J Neurol Sci"},{"key":"R42-20250821","doi-asserted-by":"crossref","first-page":"1900603","DOI":"10.1002\/adfm.201900603","article-title":"Ferrimagnetic nanochains-based mesenchymal stem cell engineering for highly efficient post-stroke recovery","volume":"29","author":"Zhang","year":"2019","journal-title":"Adv Funct Mater"},{"key":"R43-20250821","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.jconrel.2023.08.039","article-title":"Surface-tethered ROS-responsive micelle backpacks for boosting mesenchymal stem cell vitality and modulating inflammation in ischemic stroke treatment","volume":"362","author":"You","year":"2023","journal-title":"J Control Release"},{"key":"R44-20250821","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.omtm.2017.06.005","article-title":"Mesenchymal stem cells overexpressing interleukin-10 promote neuroprotection in experimental acute ischemic stroke","volume":"6","author":"Nakajima","year":"2017","journal-title":"Mol Ther Methods Clin Dev"},{"key":"R45-20250821","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1186\/s13287-018-0865-6","article-title":"cxcl12-engineered endothelial progenitor cells enhance neurogenesis and angiogenesis after ischemic brain injury in mice","volume":"9","author":"Li","year":"2018","journal-title":"Stem Cell Res Ther"},{"key":"R46-20250821","doi-asserted-by":"crossref","first-page":"e1807591","DOI":"10.1002\/adma.201807591","article-title":"Neural stem cells transfected with reactive oxygen species-responsive polyplexes for effective treatment of ischemic stroke","volume":"31","author":"Jiang","year":"2019","journal-title":"Adv Mater"},{"key":"R47-20250821","doi-asserted-by":"crossref","first-page":"294","DOI":"10.3389\/fimmu.2020.00294","article-title":"Glial Cells: Role of the immune response in ischemic stroke","volume":"11","author":"Xu","year":"2020","journal-title":"Front Immunol"},{"key":"R48-20250821","doi-asserted-by":"crossref","first-page":"5083","DOI":"10.1002\/anie.202010391","article-title":"Ultrasound controlled anti-inflammatory polarization of platelet decorated microglia for targeted ischemic stroke therapy","volume":"60","author":"Li","year":"2021","journal-title":"Angew Chem Int Ed Engl"},{"key":"R49-20250821","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1007\/s00415-009-0125-x","article-title":"Clinical determinants of infarct pattern subtypes in large vessel atherosclerotic stroke","volume":"256","author":"Bang","year":"2009","journal-title":"J Neurol"},{"key":"R50-20250821","doi-asserted-by":"crossref","first-page":"27743","DOI":"10.1021\/acsami.2c09020","article-title":"Neutrophil-biomimetic \u201cnanobuffer\u201d for remodeling the microenvironment in the infarct core and protecting neurons in the penumbra via neutralization of detrimental factors to treat ischemic stroke","volume":"14","author":"Liu","year":"2022","journal-title":"ACS Appl Mater Interfaces"},{"key":"R51-20250821","doi-asserted-by":"crossref","first-page":"114871","DOI":"10.1016\/j.addr.2023.114871","article-title":"Cell-based relay delivery strategy in biomedical applications","volume":"198","author":"Chen","year":"2023","journal-title":"Adv Drug Deliv Rev"},{"key":"R52-20250821","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aau8301","article-title":"Accessing neuroinflammation sites: Monocyte\/neutrophil-mediated drug delivery for cerebral ischemia","volume":"5","author":"Hou","year":"2019","journal-title":"Sci Adv"},{"key":"R53-20250821","first-page":"1","article-title":"Enhanced treatment for cerebral ischemia-reperfusion injury of puerarin loading liposomes through neutrophils-mediated targeted delivery","author":"Liu","year":"2021","journal-title":"Nano Research"},{"key":"R54-20250821","doi-asserted-by":"crossref","first-page":"509","DOI":"10.2147\/IJN.S394389","article-title":"Cell-based drug delivery systems with innate homing capability as a novel nanocarrier platform","volume":"18","author":"Choi","year":"2023","journal-title":"Int J Nanomedicine"},{"key":"R55-20250821","doi-asserted-by":"crossref","first-page":"10980","DOI":"10.1073\/pnas.1106634108","article-title":"Erythrocyte membrane-camouflaged polymeric nanoparticles as a biomimetic delivery platform","volume":"108","author":"Hu","year":"2011","journal-title":"Proc Natl Acad Sci"},{"key":"R56-20250821","doi-asserted-by":"crossref","first-page":"2664","DOI":"10.1039\/c3nr00015j","article-title":"\u2018Marker-of-self\u2019 functionalization of nanoscale particles through a top-down cellular membrane coating approach","volume":"5","author":"Hu","year":"2013","journal-title":"Nanoscale"},{"key":"R57-20250821","doi-asserted-by":"crossref","first-page":"e1700379","DOI":"10.1002\/mabi.201700379","article-title":"Erythrocyte-derived nanoparticles as a theranostic agent for near-infrared fluorescence imaging and thrombolysis of blood clots","volume":"18","author":"Vankayala","year":"2018","journal-title":"Macromol Biosci"},{"key":"R58-20250821","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.3390\/ijms23042223","article-title":"Cell membrane-cloaked nanotherapeutics for targeted drug delivery","volume":"23","author":"Lee","year":"2022","journal-title":"Int J Mol Sci"},{"key":"R59-20250821","doi-asserted-by":"crossref","first-page":"5417","DOI":"10.1021\/acsnano.8b00477","article-title":"Bioengineered boronic ester modified dextran polymer nanoparticles as reactive oxygen species responsive nanocarrier for ischemic stroke treatment","volume":"12","author":"Lv","year":"2018","journal-title":"ACS Nano"},{"key":"R60-20250821","doi-asserted-by":"crossref","first-page":"8577","DOI":"10.1021\/acsnano.9b01798","article-title":"Sequentially site-specific delivery of thrombolytics and neuroprotectant for enhanced treatment of ischemic stroke","volume":"13","author":"Xu","year":"2019","journal-title":"ACS Nano"},{"key":"R61-20250821","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1021\/acsnano.9b08587","article-title":"Platelet membrane biomimetic magnetic nanocarriers for targeted delivery and in situ generation of nitric oxide in early ischemic stroke","volume":"14","author":"Li","year":"2020","journal-title":"ACS Nano"},{"key":"R62-20250821","doi-asserted-by":"crossref","first-page":"4870","DOI":"10.7150\/thno.27466","article-title":"Platelet bio-nanobubbles as microvascular recanalization nanoformulation for acute ischemic stroke lesion theranostics","volume":"8","author":"Li","year":"2018","journal-title":"Theranostics"},{"key":"R63-20250821","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.actbio.2021.12.009","article-title":"Rescuing ischemic stroke by biomimetic nanovesicles through accelerated thrombolysis and sequential ischemia-reperfusion protection","volume":"140","author":"Yu","year":"2022","journal-title":"Acta Biomater"},{"key":"R64-20250821","doi-asserted-by":"crossref","first-page":"e2101526","DOI":"10.1002\/advs.202101526","article-title":"Macrophage-disguised manganese dioxide nanoparticles for neuroprotection by reducing oxidative stress and modulating inflammatory microenvironment in acute ischemic stroke","volume":"8","author":"Li","year":"2021","journal-title":"Adv Sci"},{"key":"R65-20250821","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1186\/s12951-021-01067-0","article-title":"Functionalized nanoparticles with monocyte membranes and rapamycin achieve synergistic chemoimmunotherapy for reperfusion-induced injury in ischemic stroke","volume":"19","author":"Wang","year":"2021","journal-title":"J Nanobiotechnol"},{"key":"R66-20250821","doi-asserted-by":"crossref","first-page":"3847","DOI":"10.1021\/acsomega.0c05632","article-title":"Macrophage-engineered vesicles for therapeutic delivery and bidirectional reprogramming of immune cell polarization","volume":"6","author":"Neupane","year":"2021","journal-title":"ACS Omega"},{"key":"R67-20250821","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1186\/s12967-020-02278-z","article-title":"LincRNA-EPS in biomimetic vesicles targeting cerebral infarction promotes inflammatory resolution and neurogenesis","volume":"18","author":"Zhang","year":"2020","journal-title":"J Transl Med"},{"key":"R68-20250821","doi-asserted-by":"crossref","first-page":"102570","DOI":"10.1016\/j.nano.2022.102570","article-title":"Construction of bionanoparticles based on Angelica polysaccharides for the treatment of stroke","volume":"44","author":"Su","year":"2022","journal-title":"Nanomedicine"},{"key":"R69-20250821","first-page":"1272","article-title":"Neutrophil membrane-derived nanovesicles alleviate inflammation to protect mouse brain injury from ischemic stroke","volume":"13","author":"Dong","year":"2019","journal-title":"ACS Nano"},{"key":"R70-20250821","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1039\/C8RA06688D","article-title":"Neutrophil-mediated and low density lipoprotein receptor-mediated dual-targeting nanoformulation enhances brain accumulation of scutellarin and exerts neuroprotective effects against ischemic stroke","volume":"9","author":"Dang","year":"2019","journal-title":"RSC Adv"},{"key":"R71-20250821","doi-asserted-by":"crossref","first-page":"e2311803","DOI":"10.1002\/adma.202311803","article-title":"Neutrophil membrane-camouflaged polyprodrug nanomedicine for inflammation suppression in ischemic stroke therapy","volume":"36","author":"Zhao","year":"2024","journal-title":"Adv Mater"},{"key":"R72-20250821","doi-asserted-by":"crossref","first-page":"5033","DOI":"10.1021\/acsnano.2c12840","article-title":"Multiscale NIR-II Imaging-guided brain-targeted drug delivery using engineered cell membrane nanoformulation for Alzheimer\u2019s disease therapy","volume":"17","author":"Huang","year":"2023","journal-title":"ACS Nano"},{"key":"R73-20250821","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1007\/s12975-022-00984-y","article-title":"Neural stem cells therapy for ischemic stroke: Progress and challenges","volume":"13","author":"Zhao","year":"2022","journal-title":"Transl Stroke Res"},{"key":"R74-20250821","doi-asserted-by":"crossref","first-page":"e1902011","DOI":"10.1002\/smll.201902011","article-title":"Targeted drug delivery to stroke via chemotactic recruitment of nanoparticles coated with membrane of engineered neural stem cells","volume":"15","author":"Ma","year":"2019","journal-title":"Small"},{"key":"R75-20250821","doi-asserted-by":"crossref","first-page":"e2101158","DOI":"10.1002\/smtd.202101158","article-title":"Engineering CXCL12 biomimetic decoy-integrated versatile immunosuppressive nanoparticle for ischemic stroke therapy with management of overactivated brain immune microenvironment","volume":"6","author":"Shi","year":"2022","journal-title":"Small Methods"},{"key":"R76-20250821","doi-asserted-by":"crossref","first-page":"2006169","DOI":"10.1002\/adfm.202006169","article-title":"Engineering stem cell derived biomimetic vesicles for versatility and effective targeted delivery","volume":"30","author":"Wu","year":"2020","journal-title":"Adv Funct Mater"},{"key":"R77-20250821","doi-asserted-by":"crossref","first-page":"110298","DOI":"10.1016\/j.msec.2019.110298","article-title":"Cell membrane-coated nanosized active targeted drug delivery systems homing to tumor cells: A review","volume":"106","author":"He","year":"2020","journal-title":"Mater Sci Eng C Mater Biol Appl"},{"key":"R78-20250821","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.molmed.2018.01.006","article-title":"Manufacturing exosomes: a promising therapeutic platform","volume":"24","author":"Colao","year":"2018","journal-title":"Trends Mol Med"},{"key":"R79-20250821","doi-asserted-by":"crossref","first-page":"e2000673","DOI":"10.1002\/smll.202000673","article-title":"Safety considerations of cancer nanomedicine-a key step toward translation","volume":"16","author":"Liu","year":"2020","journal-title":"Small"},{"key":"R80-20250821","doi-asserted-by":"crossref","first-page":"5533","DOI":"10.2174\/1381612826666200614180253","article-title":"Exosomes in ischemic stroke","volume":"26","author":"Nozohouri","year":"2020","journal-title":"Curr Pharm Des"},{"key":"R81-20250821","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/s41569-020-0389-5","article-title":"Native and bioengineered extracellular vesicles for cardiovascular therapeutics","volume":"17","author":"de Abreu","year":"2020","journal-title":"Nat Rev Cardiol"},{"key":"R82-20250821","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1242\/jcs.074088","article-title":"Selective transfer of exosomes from oligodendrocytes to microglia by macropinocytosis","volume":"124","author":"Fitzner","year":"2011","journal-title":"J Cell Sci"},{"key":"R83-20250821","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12951-021-00879-4","article-title":"Surface-modified engineered exosomes attenuated cerebral ischemia\/reperfusion injury by targeting the delivery of quercetin towards impaired neurons","volume":"19","author":"Guo","year":"2021","journal-title":"J Nanobiotechnol"},{"key":"R84-20250821","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1161\/CIRCULATIONAHA.120.045765","article-title":"Extracellular vesicle-mediated delivery of circular RNA SCMH1 promotes functional recovery in rodent and nonhuman primate ischemic stroke models","volume":"142","author":"Yang","year":"2020","journal-title":"Circulation"},{"key":"R85-20250821","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.brainres.2019.04.009","article-title":"Exosome-shuttled miR-92b-3p from ischemic preconditioned astrocytes protects neurons against oxygen and glucose deprivation","volume":"1717","author":"Xu","year":"2019","journal-title":"Brain Res"},{"key":"R86-20250821","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1097\/WNR.0000000000001280","article-title":"Role of exosomes induced by remote ischemic preconditioning in neuroprotection against cerebral ischemia","volume":"30","author":"Li","year":"2019","journal-title":"Neuroreport"},{"key":"R87-20250821","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.biomaterials.2017.10.012","article-title":"Surface functionalized exosomes as targeted drug delivery vehicles for cerebral ischemia therapy","volume":"150","author":"Tian","year":"2018","journal-title":"Biomaterials"},{"key":"R88-20250821","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s12951-019-0461-7","article-title":"Exosome-mediated targeted delivery of miR-210 for angiogenic therapy after cerebral ischemia in mice","volume":"17","author":"Zhang","year":"2019","journal-title":"J Nanobiotechnol"},{"key":"R89-20250821","doi-asserted-by":"crossref","first-page":"100129","DOI":"10.1016\/j.medidd.2022.100129","article-title":"Engineered biomimetic drug-delivery systems for ischemic stroke therapy","volume":"15","author":"Yang","year":"2022","journal-title":"Medicine in Drug Discov"},{"key":"R90-20250821","doi-asserted-by":"crossref","first-page":"119942","DOI":"10.1016\/j.biomaterials.2020.119942","article-title":"Mesenchymal stem cell-derived magnetic extracellular nanovesicles for targeting and treatment of ischemic stroke","volume":"243","author":"Kim","year":"2020","journal-title":"Biomaterials"},{"key":"R91-20250821","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1021\/acs.nanolett.9b04974","article-title":"Bioinspired nanosponge for salvaging ischemic stroke via free radical scavenging and self-adapted oxygen regulating","volume":"20","author":"Shi","year":"2020","journal-title":"Nano Lett"}],"container-title":["Chinese Medical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/CM9.0000000000003685","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:03:26Z","timestamp":1786035806000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/CM9.0000000000003685"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,4]]},"references-count":91,"journal-issue":{"issue":"16","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/cm9.0000000000003685","relation":{},"ISSN":["0366-6999","2542-5641"],"issn-type":[{"value":"0366-6999","type":"print"},{"value":"2542-5641","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,4]]},"assertion":[{"value":"2024-12-21","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}}]}}